MedTrace Logo

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation

NCT06503770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 284

Last updated 2025-05-20

No results posted yet for this study

Summary

The aim of this study is to describe the forced expiratory volume in 1 second (FEV1) decline and natural disease evolution in patients affected by CLAD-BOS after lung transplantation and receiving an immunosuppressive therapy as standard of care.

Conditions

  • Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)

Sponsors & Collaborators

  • Zambon SpA

    lead INDUSTRY

Principal Investigators

  • Bucchioni, MD · Zambon SpA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-27
Primary Completion
2025-04-02
Completion
2025-04-02

Countries

  • United States
  • Belgium
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06503770 on ClinicalTrials.gov